Co-Authors
This is a "connection" page, showing publications co-authored by Kaijin Xu and Qiang Fang.
Connection Strength
0.773
-
[Management of COVID-19: the Zhejiang experience]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25; 49(2):147-157.
Score: 0.221
-
[Management of corona virus disease-19 (COVID-19): the Zhejiang experience]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 Feb 21; 49(1):147-157.
Score: 0.217
-
Clinical efficacy of methylprednisolone and the combined use of lopinavir/ritonavir with arbidol in treatment of coronavirus disease 2019. J Med Virol. 2021 07; 93(7):4446-4453.
Score: 0.059
-
Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China. Emerg Infect Dis. 2020 06; 26(6):1335-1336.
Score: 0.055
-
Coronavirus disease 2019 (COVID-19): chest CT characteristics benefit to early disease recognition and patient classification-a single center experience. Ann Transl Med. 2020 Jun; 8(11):679.
Score: 0.055
-
[CT imaging features of patients with different clinical types of COVID-19]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25; 49(2):198-202.
Score: 0.055
-
[CT imaging features of patients with different clinical types of coronavirus disease 2019 (COVID-19)]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25; 49(1):198-202.
Score: 0.055
-
Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ. 2020 04 21; 369:m1443.
Score: 0.055